BeMORE: a novel method for detection of adverse fetal effects induced by drugs.
We describe a unique new collaboration which allows linkage of administrative databases in Southern Israel, and hence ascertain risk/safety of prescription drugs in pregnancy. The advantages of this system include availability of rigorous data confounders, solid data on maternal conditions for which the drug is given, ability to capture all cases of elective abortions and not just live births, and ability to construct drug doses.
Department of Epidemiology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.
Ilan
I
Matok
Amalia
A
Levy
Rafael
R
Gorodischer
Eitan
E
Lunenfeld
Yehuda
Y
Limony
Gideon
G
Koren
D000032:Abortion, Therapeutic; D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005333:Fetus / Q000002:abnormalities / Q000187:drug effects*; D006801:Humans; D007557:Israel / Q000453:epidemiology; D008875:Middle Aged; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000453:epidemiology*; D012042:Registries; D012189:Retrospective Studies; D055815:Young Adult